酸化后的Pin1催化型构造调节:在细胞信号和药物发现方面是一个独特的检查点
Kun Ping Lu1,2, Xiao Zhen Zhou1,3,4
1Departments of Biochemistry and Oncology, Schulich School of Medicine & Dentistry, Western University, London, ON N6G 2V4, Canada.
Science signaling
|June 18, 2024
概括
Pin1 (Peptidyl-prolyl cis-trans异构酶) 在酸化后调节蛋白质功能. 准Pin1 的目标
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 细胞信号传输 细胞信号传输
背景情况:
- 蛋白质酸化是一种关键的细胞信号传递机制.
- Pin1通过酸化后的 cis-trans 异构化调节蛋白质功能.
- 人们越来越了解pin1在细胞过程中的作用,但缺乏检测其构造状态的工具.
研究的目的:
- 审查了解健康和疾病中的Pin1信号的进展.
- 突出Pin1的形状调节作为疾病发展和治疗的关键检查点.
主要方法:
- 对Pin1功能,抑制和抗体发育的现有文献的综述.
- 对研究Pin1目标的cis和trans conformations的研究进行分析.
- 检查Pin1在癌症和神经退行等与年龄相关的疾病中的作用.
主要成果:
- Pin1 的 cis 和 trans 构造表现出不同的和相反的细胞功能.
- 皮恩1介导的形状变化的失调有助于致病的产生.
- 1抑制剂和特定抗体是研究和准Pin1的新兴工具.
结论:
- 通过Pin1进行的符合性调节是一个至关重要的,但被低估的信号传导检查点.
- 针对Pin1为各种与年龄相关的疾病提供治疗潜力.
- 需要进一步开发工具来检测和调节Pin1形状.
相关概念视频
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Negative Regulator Molecules
35.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
Positive Regulator Molecules
5.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.4K
Assembly of Signaling Complexes
5.7K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.7K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K


